What are the indications, recommended dosing, contraindications, adverse effects, and drug interactions for Ester‑C (calcium ascorbate) oral tablets?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ester-C (Calcium Ascorbate) Oral Tablet

Ester-C is a calcium ascorbate formulation of vitamin C indicated for vitamin C supplementation, with standard dosing of 50-500 mg/day depending on clinical context, minimal contraindications, excellent safety profile, and few clinically significant drug interactions.

Indications

Ester-C (calcium ascorbate) is indicated for:

  • Prevention and treatment of vitamin C deficiency (scurvy)
  • Supplementation in chronic oxidative stress conditions: diabetes mellitus, heart failure, smoking, alcoholism, severe COPD, and chronic dialysis 1
  • Malabsorption states including post-bariatric surgery 1
  • General health maintenance in individuals with inadequate dietary intake

The 2022 ESPEN guidelines provide the most authoritative framework for vitamin C supplementation across clinical contexts 1.

Recommended Dosing

Standard Populations

  • Healthy individuals: 50-100 mg/day (daily recommended dose) 1
  • General supplementation: 500 mg/day 1

Special Populations Requiring Higher Doses

  • Chronic oxidative stress conditions (diabetes, heart failure, smoking, alcoholism, severe COPD, chronic dialysis): 200-500 mg/day 1
  • Malabsorption states: 200-500 mg/day may be required 1
  • Post-bariatric surgery: 200-500 mg/day 1

Critical Illness (Note: Requires IV Administration)

For completeness, critically ill patients require 2-3 g/day IV during acute inflammation, but this exceeds oral tablet capabilities 1, 2.

Formulation Considerations

Calcium ascorbate (Ester-C) may offer better gastrointestinal tolerance compared to regular ascorbic acid, particularly in acid-sensitive individuals. A 2006 study demonstrated significantly fewer epigastric adverse effects (37.5% vs 62.5%) and better tolerability ratings (72% "very good" vs 54%) with Ester-C compared to ascorbic acid 3. However, bioavailability differences remain debated, with one animal study suggesting enhanced potency 4 while a 2024 human study showed minimal differences at 250 mg but some immune benefits at 500 mg 5.

Contraindications

Absolute contraindications for high-dose vitamin C supplementation include:

  • Renal insufficiency or chronic hemodialysis patients (selenium excretion concerns apply; vitamin C itself requires monitoring) 6
  • Unusual forms of iron overload (hemochromatosis, thalassemia) - vitamin C enhances iron absorption 6
  • Active oxalate stone formers - theoretical risk of calcium oxalate stone formation 6
  • Known hypersensitivity to calcium ascorbate or any component

Important caveat: The FDA drug label evidence 7 pertains to estrogen products (DEPO-Estradiol), NOT Ester-C, and should be disregarded for this question.

Adverse Effects

Vitamin C, including calcium ascorbate formulations, demonstrates excellent safety at recommended doses:

Common (Dose-Dependent)

  • Gastrointestinal effects: Nausea, diarrhea, abdominal cramping (typically at doses >1000 mg/day)
  • Epigastric discomfort: Significantly reduced with Ester-C vs regular ascorbic acid 3

Theoretical Concerns (Largely Unfounded)

Extensive literature review demonstrates that in healthy individuals, gram doses do NOT induce 6:

  • Renal calcium oxalate stones
  • Systemic conditioning (rebound scurvy)
  • Uricosuria
  • Vitamin B12 destruction
  • Mutagenicity

Monitoring Considerations

  • Renal function: In patients with renal insufficiency
  • Iron studies: In patients with iron overload disorders
  • Urinary oxalate: In known stone formers

Drug Interactions

Vitamin C has minimal clinically significant drug interactions at standard supplementation doses:

Pharmacodynamic Interactions

  • Enhanced iron absorption: Beneficial in iron deficiency; problematic in iron overload 6
  • Potential interaction with anticoagulants: Theoretical only; not clinically significant at standard doses
  • Chemotherapy agents: High-dose IV vitamin C (not oral tablets) may interact with certain chemotherapy; standard oral doses are safe 8, 9

Pharmacokinetic Considerations

Oral vitamin C absorption is tightly regulated by three mechanisms: intestinal absorption, tissue accumulation, and renal reabsorption 9. Even with high oral doses, plasma concentrations rarely exceed 250 μmol/L, limiting interaction potential 9.

Clinical Pearls

  • Oral bioavailability is saturable: Doses above 500 mg provide diminishing returns for plasma concentration 9
  • Divided dosing: For doses >500 mg/day, divide into 2-3 doses for better absorption
  • Calcium content: Ester-C contains calcium; consider in patients requiring calcium restriction
  • Inflammation affects interpretation: Plasma vitamin C levels decline rapidly with CRP >10 mg/L, making measurement unreliable during acute illness 1
  • Clinical trial for suspected deficiency: 1 g/day for at least one week should not be delayed if scurvy is suspected 1

1 1 1 3 6 9

Related Questions

Does ascorbic acid have a role in acidifying urine, and in which clinical situations is it indicated for urine acidification?
What dose of ascorbic acid (vitamin C) should be given to acidify urinary pH in adults?
What does the presence of ascorbic acid in urine indicate?
Are standard doses of vitamin C (ascorbic acid) and zinc safe for a patient with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency?
Are the ingredients vitamin C (L‑ascorbic acid), citric acid, sodium carbonate, sorbitol, flavoring agents, polyvinylpyrrolidone, polyethylene glycol, cyclamates, saccharin, and riboflavin harmful when used in a dietary supplement?
How should I transition a patient with atrial fibrillation from warfarin (Sintrom) to therapeutic enoxaparin (Lovenox)?
What is the normal frequency of bowel sounds and how do hypoactive, hyperactive, absent, and tinkling bowel sounds differ?
What is the annual risk that a flat colorectal lesion classified as Japanese Narrow-Band Imaging Expert Team (JNET) type 2A (low‑grade intramucosal neoplasia) will progress to higher‑grade dysplasia or invasive cancer?
I am a smoker who sleeps in a cold room and wake with continuous central chest heaviness, no radiation, and a dry cough that becomes productive after about two hours; what is the most likely diagnosis?
For buccal mucosa irritation caused by dental trauma, is Aftamed oral spray (hyaluronic acid) more effective than Keto oral paste (ketoprofen)?
What are the benefits, risks, and future pregnancy implications of a cesarean section?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.